BBS-Bioactive Bone Substitutes (OHEL:BONEH) ROIC % : -34.92% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is BBS-Bioactive Bone Substitutes ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. BBS-Bioactive Bone Substitutes's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was -34.92%.

As of today (2024-05-24), BBS-Bioactive Bone Substitutes's WACC % is 5.08%. BBS-Bioactive Bone Substitutes's ROIC % is -32.79% (calculated using TTM income statement data). BBS-Bioactive Bone Substitutes earns returns that do not match up to its cost of capital. It will destroy value as it grows.

BBS-Bioactive Bone Substitutes ROIC % Historical Data

The historical data trend for BBS-Bioactive Bone Substitutes's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BBS-Bioactive Bone Substitutes ROIC % Chart

BBS-Bioactive Bone Substitutes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROIC %

Get a 7-Day Free Trial

-14.79

-26.34

-25.80

-28.64

-33.67

BBS-Bioactive Bone Substitutes Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROIC %	Get a 7-Day Free Trial											-25.28	-27.72	-27.63	-29.87	-34.92

Competitive Comparison of BBS-Bioactive Bone Substitutes's ROIC %

For the Medical Devices subindustry, BBS-Bioactive Bone Substitutes's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BBS-Bioactive Bone Substitutes's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BBS-Bioactive Bone Substitutes's ROIC % distribution charts can be found below:

* The bar in red indicates where BBS-Bioactive Bone Substitutes's ROIC % falls into.

BBS-Bioactive Bone Substitutes ROIC % Calculation

BBS-Bioactive Bone Substitutes's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

	ROIC % (A: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2022 )	+	Invested Capital (A: Dec. 2023 ))	/ count )
=	-3.367 * ( 1 - 0% )	/	( (10.267	+	9.732)	/ 2 )
=	-3.367	/	9.9995
=	-33.67 %

where

	Invested Capital		(A: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.688	-	0.205	-	( 1.517	-	max(0, 1.701	-	1.917	+	1.517	))
=	10.267

	Invested Capital		(A: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.613	-	0.239	-	( 1.971	-	max(0, 1.377	-	2.019	+	1.971	))
=	9.732

BBS-Bioactive Bone Substitutes's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

	ROIC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-3.586 * ( 1 - 0% )	/	( (10.809	+	9.732)	/ 2 )
=	-3.586	/	10.2705
=	-34.92 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.727	-	0	-	( 1.671	-	max(0, 2.146	-	2.064	+	1.671	))
=	10.809

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.613	-	0.239	-	( 1.971	-	max(0, 1.377	-	2.019	+	1.971	))
=	9.732

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, BBS-Bioactive Bone Substitutes's WACC % is 5.08%. BBS-Bioactive Bone Substitutes's ROIC % is -32.79% (calculated using TTM income statement data).

Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

BBS-Bioactive Bone Substitutes ROIC % Related Terms

Thank you for viewing the detailed overview of BBS-Bioactive Bone Substitutes's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BBS-Bioactive Bone Substitutes PLC (OHEL:BONEH) » Definitions » ROIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kiviharjunlenkki 6, Oulu, FIN, 90220

Website

http://www.bbs-artebone.fi

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs, and manufactures bioactive bone-graft substitute implants. Its ortho-biological product ARTEBONE, which is based on tricalcium phosphate and a natural spectrum of bone proteins has the capability of bone regeneration.

BBS-Bioactive Bone Substitutes (OHEL:BONEH) Headlines

No Headlines